These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37581749)

  • 41. Impact of overdose prevention sites during a public health emergency in Victoria, Canada.
    Pauly B; Wallace B; Pagan F; Phillips J; Wilson M; Hobbs H; Connolly J
    PLoS One; 2020; 15(5):e0229208. PubMed ID: 32438390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Walk With Me: reducing harm and confronting the toxic drug poisoning crisis in small British Columbia cities through community engaged research.
    Wideman T; Karsten S;
    Harm Reduct J; 2024 May; 21(1):106. PubMed ID: 38822343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis.
    Moustaqim-Barrette A; Papamihali K; Crabtree A; Graham B; Karamouzian M; Buxton JA
    Drug Alcohol Depend; 2019 Dec; 205():107609. PubMed ID: 31654839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
    Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
    [No Abstract]   [Full Text] [Related]  

  • 45. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
    Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol.
    Nosyk B; Slaunwhite A; Urbanoski K; Hongdilokkul N; Palis H; Lock K; Min JE; Zhao B; Card KG; Barker B; Meilleur L; Burmeister C; Thomson E; Beck-McGreevy P; Pauly B
    BMJ Open; 2021 Jun; 11(6):e048353. PubMed ID: 34108170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Overdose Crisis and Using Alone: Perspectives of People Who Use Drugs in Rural and Semi-Urban Areas of British Columbia.
    Fernando S; Hawkins J; Kniseley M; Sikora M; Robson J; Snyder D; Battle C; Salmon A
    Subst Use Misuse; 2022; 57(12):1864-1872. PubMed ID: 36096482
    [No Abstract]   [Full Text] [Related]  

  • 48. Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.
    Collins AB; Boyd J; Mayer S; Fowler A; Kennedy MC; Bluthenthal RN; Kerr T; McNeil R
    Int J Drug Policy; 2019 Nov; 73():199-207. PubMed ID: 31542327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings.
    MacKinnon L; Socías ME; Bardwell G
    J Subst Abuse Treat; 2020 Dec; 119():108153. PubMed ID: 33032862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decriminalization or police mission creep? Critical appraisal of law enforcement involvement in British Columbia, Canada's decriminalization framework.
    Michaud L; McDermid J; Bailey A; Singh Kelsall T
    Int J Drug Policy; 2024 Jul; 129():104478. PubMed ID: 38879942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
    Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
    PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program.
    Karamouzian M; Kuo M; Crabtree A; Buxton JA
    Int J Drug Policy; 2019 Sep; 71():157-163. PubMed ID: 30691944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acceptability of technological solutions for overdose monitoring: Perspectives of people who use drugs.
    Tsang VWL; Papamihali K; Crabtree A; Buxton JA
    Subst Abus; 2021; 42(3):284-293. PubMed ID: 31657675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study.
    Ferguson M; Choisil P; Lamb J; Burmeister C; Newman C; Lock K; Tobias S; Liu L; Buxton JA
    Harm Reduct J; 2023 Dec; 20(1):178. PubMed ID: 38093272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of mathematical modelling in aiding public health policy decision-making: A case study of the BC opioid overdose emergency.
    Irvine MA; McGowan R; Hammond K; Davison C; Coombs D; Gilbert M
    Int J Drug Policy; 2021 Feb; 88():102603. PubMed ID: 31753602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study.
    Collins AB; Boyd J; Hayashi K; Cooper HLF; Goldenberg S; McNeil R
    Int J Drug Policy; 2020 Feb; 76():102641. PubMed ID: 31887644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: Controlled interrupted time series.
    Panagiotoglou D
    PLoS One; 2022; 17(3):e0265665. PubMed ID: 35316284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "We just don't have the space for it": Geographies of survival and spatial triage in overdose prevention sites.
    Olding M; Boyd J; Kerr T; McNeil R
    Health Place; 2023 Sep; 83():103067. PubMed ID: 37352615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.
    Olding M; Enns B; Panagiotoglou D; Shoveller J; Harrigan PR; Barrios R; Kerr T; Montaner JSG; Nosyk B
    J Int AIDS Soc; 2017 Sep; 20(1):21941. PubMed ID: 28953322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.